3-hydroxyephedrine has been researched along with Cardiomyopathy, Dilated in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hadamitzky, M; Hartmann, F; Nekolla, S; Richardt, G; Schwaiger, M; Seyfarth, M; Ziegler, S | 1 |
| L'Abbate, A; Sambuceti, G | 1 |
2 other study(ies) available for 3-hydroxyephedrine and Cardiomyopathy, Dilated
| Article | Year |
|---|---|
Regional patterns of myocardial sympathetic denervation in dilated cardiomyopathy: an analysis using carbon-11 hydroxyephedrine and positron emission tomography.
Topics: Adult; Carbon Radioisotopes; Cardiomyopathy, Dilated; Contrast Media; Ephedrine; Female; Heart; Humans; Male; Middle Aged; Regression Analysis; Sympathetic Nervous System; Tomography, Emission-Computed | 1999 |
Studying the neuronal side of the synaptic cleft. A tool for investigating the paradox of sympathetic nervous system and heart failure in dilated cardiomyopathy.
Topics: 3-Iodobenzylguanidine; Adrenergic Agents; Animals; Cardiomyopathy, Dilated; Catecholamines; Ephedrine; Heart Failure; Humans; Radionuclide Imaging; Radiopharmaceuticals; Receptors, Adrenergic; Sympathetic Nervous System; Synaptic Transmission | 2001 |